
Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory – Potential Safety Risk Including the following products: Opana ER (oxymorphone hydrochloride) Extended-Release Tablets CII Opana (oxymorphone hydrochloride) CII Oxymorphone hydrochloride Tablets CII PERCOCET (oxycodone hydrochloride and acetaminophen USP) Tablets CII PERCODAN (oxycodone hydrochloride and aspirin, USP) Tablets CII ENDOCET (oxycodone hydrochloride and acetaminophen Continue Reading …







Follow Us!